Last updated:
Filter results
You can narrow down the results using the filters
Publication type
Topic
Disease
565 results
Search results
-
enHealth fact sheet – Per- and polyfluoroalkyl substances (PFAS)
This fact sheet provides key information on PFAS. -
enHealth guidance – Per- and polyfluoroalkyl substances (PFAS)
This document provides updated PFAS health guidance in light of recently completed research into the human health effects of PFAS and exposure in Australia. -
Invasive Group A streptococcal disease – Surveillance case definition
This document contains the surveillance case definition for invasive Group A streptococcal disease (iGAS), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Invasive Group A Streptococcal (iGAS) Disease – CDNA National guidelines for Public Health Units
These guidelines outline Australia’s national minimum standard for surveillance, laboratory testing, case management and contact management for Invasive Group A Streptococcal (iGAS) disease. -
West Nile/Kunjin virus infection – Surveillance case definition
This document contains the surveillance case definition for West Nile/Kunjin virus infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Murray Valley encephalitis virus infection – Surveillance case definition
This document contains the surveillance case definition for Murray Valley encephalitis virus infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
HIV Taskforce report
This report provides advice to the Australian Government on HIV prevention, testing, treatment, awareness raising, decriminalisation, destigmatisation and partnership. -
enHealth literature review – Vapour intrusions: hazardous ground gases
The report aims to guide health assessment and management of sites impacted by vapor intrusion in Australia. -
enHealth guidance – The human health risk assessment of volatile chlorinated hydrocarbon vapour intrusion
This document summarizes health risks related to vapor intrusion. It aligns with Agency for Toxic Substances and Disease Registry (ATSDR) guidelines for assessing the public health impact of vapour intrusion. -
Diphtheria – Surveillance case definition
This document contains the surveillance case definition for diphtheria, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Gonococcal infection – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for gonococcal infection. -
National Health and Climate Strategy
The National Health and Climate Strategy sets out a whole-of-government plan to address the health and wellbeing impacts of climate change and address the contribution of the health system to climate change. -
National Health and Climate Strategy – Final thematic stakeholder engagement report
This report analyses responses to the consultation paper from 2 June 2023 to 24 July 2023. These responses informed the development of the National Health and Climate Strategy. -
Invasive Group A Streptococcal disease (iGAS) – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for iGAS disease. -
Statement of Intent – 10 November 2023
This statement outlines how we will work together with state and territory governments to support the establishment and operation of the interim Australian CDC. It includes a timeline for delivering an agreement to support the fully developed Australian CDC. -
Role and functions of an Australian Centre for Disease Control
This discussion paper outlines the draft mission and purpose statements for the Centre for Disease Control (CDC). It includes an outline of its potential scope of functions, examples of how it could improve public health in Australia, and principles guiding its design. -
Biotoxins (indoor damp and mould) Clinical Pathway
The document supports decision-making for general practitioners and other medical professionals for the diagnosis, treatment, and management of patients presenting with biotoxin-related illnesses. -
HIV Taskforce communique – 20 October 2023
This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 20 October 2023. -
Syphilis (congenital) – Surveillance case definition
This document contains the surveillance case definition for syphilis (congenital), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
PHLN referral pathway for poliovirus confirmatory testing
This document explains how to collect and transport specimens, and the referral pathway to confirm poliovirus detected in wastewater. -
HIV Taskforce communique – 11 August 2023
This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 11 August 2023. -
Respiratory syncytial virus – Surveillance case definition
This document contains the surveillance case definition for respiratory syncytial virus, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
HIV Taskforce communique – 29 June 2023
This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 29 June 2023. -
Joint national Japanese encephalitis virus outbreak response plan
This plan is the first Australian Response Plan for Japanese encephalitis. It provides a framework for nationally co-operative response arrangements for managing Japanese encephalitis virus. -
HIV Taskforce communique – 3 May 2023
This document presents a summary of discussions and decisions by the Human Immunodeficiency Virus (HIV) Taskforce on 3 May 2023.